Nxera Pharma – formerly known as Sosei Group or Sosei Heptares – and Antiverse, a techbio company designing antibodies for challenging targets, have announced...
Absci Corporation a data-first generative AI drug creation company, and Twist Bioscience Corporation a company enabling customers to succeed through its offering of high-quality synthetic...
Gestalt, a leader in digital pathology solutions, and Paige, the leader in next-generation AI technology for pathology, are excited to announce a strategic partnership...
Medidata, a Dassault Systèmes brand and the leading provider of clinical trial solutions to the life sciences industry, announced a partnership with neuroscience solutions...
Quris-AI (Quris), a leading Bio-AI company focused on revolutionizing the pharmaceutical drug development process, announced the successful asset acquisition of Nortis, recently known as...
Aignostics, a global artificial intelligence (AI) company that turns complex multi-modal pathology data into transformative insights, announced that it has raised $34 million in Series...
Tevogen Bio, a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T cell therapeutics to treat infectious disease and cancers, announces its Artificial Intelligence...